N440K variant of SARS-CoV-2 has Higher Infectious Fitness
Abstract
Several variants of SARS-CoV-2 have been emerging across the globe, continuing to threaten the efforts to end COVID-19 pandemic. Recent data indicate the prevalence of variants with N440K Spike substitution in several parts of India, which is under the second wave of the pandemic. Here, we first analyze the prevalence of N440K variants within the sequences submitted from India and identify a rising trend of its spread across various clusters. We then compare the replicative fitness and infectivity of a prototype of this variant with two other previously prevalent strains. The N440K variant produced ten times higher infectious viral titers than a prevalent A2a strain, and over 1000 folds higher titers than a much less prevalent A3i strain prototype in Caco2 cells. Similar results were detected in Calu-3 cells as well, confirming the increased potency of the N440K variant. Interestingly, A3i strain showed the highest viral RNA levels, but the lowest infectious titers in the culture supernatants, indicating the absence of correlation between the RNA content and the infectivity of the sample. N440K mutation has been reported in several viral sequences across India and based on our results, we predict that the higher infectious titers achieved by N440K variant could possibly lead to its higher rate of transmission. Availability of more sequencing data in the immediate future would help understand the potential spread of this variant in more detail.
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Virological characteristics of the SARS-CoV-2 KP.2 variant
Yu Kaku, Keiya Uriu, … Kei Sato·The Lancet Infectious DiseasesPeer-reviewed·May 20, 2024
- Virological characteristics of the SARS-CoV-2 KP.3, LB.1 and KP.2.3 variants
Yu Kaku, Maximilian Stanley Yo, … Kei Sato·The Lancet Infectious DiseasesPeer-reviewed·Jun 27, 2024
- The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity
E. C. Thomson, L. E. Rosen, … J. Nichols·bioRxiv·Nov 4, 2020
- Nucleocapsid mutation R203K/G204R increases the infectivity, fitness and virulence of SARS-CoV-2
- First description of two immune escape indian B.1.1.420 and B.1.617.1 SARS-CoV2 variants in France
Vincent Garcia, Véronique Vig, … Philippe Halfon·bioRxiv·May 12, 2021
- Virological characteristics of the SARS-CoV-2 KP.3.1.1 variant
Yu Kaku, Keiya Uriu, … Kei Sato·The Lancet Infectious DiseasesPeer-reviewed·Aug 16, 2024